Abstract
Objectives and design
Dendritic cells (DCs) are one of the key immune cells in bridging innate and adaptive immune response against Mycobacterium tuberculosis (Mtb) infection. Interferons (IFNs) play important roles in regulating DC activation and function. Virus-inhibitory protein, endoplasmic reticulum-associated, interferon-inducible (Viperin) is one of the important IFN-stimulated genes (ISGs), and elicits host defense against infection.
Methods
We investigated the effects and mechanisms of Viperin on DC activation and function using Viperin deficient bone marrow-derived dendritic cells (BMDCs) during Mtb infection.
Results
Viperin deficiency enhanced phagocytic activity and increased clearance of Mtb in DCs, produced higher abundance of NO, cytokine including interleukin-12 (IL-12), Tumor necrosis factor-α (TNF-α), IL-1β, IL-6 and chemokine including CXCL1, CXCL2 and CXCL10, elevated MHC I, MHC II and co-stimulatory molecules expression, and enhanced CD4+ and CD8+ T cell responses. Mechanistically, Viperin deficiency promoted DC activation and function through NF-κB p65 activation. NF-κB p65 inhibitor prevented cytokine and chemokine production, and co-stimulatory molecules expression promoted by Viperin deficiency.
Conclusions
These results suggest that Mtb induced Viperin expression could impair the activation of host defense function of DCs and DC-T cell cross talk during Mtb infection. This research may provide a potential target for future HDT in TB therapy.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Background
Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) infection is one of the leading killers among chronic infectious diseases worldwide. It has been reported that 9.9 million new TB cases and 1.5 million TB deaths in 2020, and deaths from TB have risen for the first time within 15 years [1]. Although the standard therapy known as Directly Observed Treatment, Short course (DOTS) is effective for treating drug-sensitive TB, lengthy duration of treatment and drug-induced tissue toxicity, contributes to patient non-compliance and drug resistance toward Mtb [2]. Hence, it is imperative to improve current or develop new TB treatment strategies. As a long-term evolved pathogen, Mtb is capable to evade both innate and adaptive immunity. Therefore, host-directed therapy (HDT) as an emerging concept, which can modulate host immune response with small molecules, holds the promising to avoid drug resistance and achieve efficiency for anti-TB treatment.
Dendritic cells (DCs) are professional antigen-presenting cells (APCs) linking innate and adaptive immune responses, and key component of the host defense system during Mtb infection [3]. Immune response of DCs to Mtb infection is initiated following the uptake of Mtb by phagocytes [4]. Reactive oxygen/nitrogen species and NO production are produced and play critical roles in determining the fate of intracellular Mtb within phagocytes [5]. The interaction between phagocyte pattern recognition receptors (PRRs) and Mtb antigens triggers the production of various proinflammatory cytokines, including interleukin-12 (IL-12), tumor necrosis factor-α (TNF-α), IL-1β and IL-6, as well as chemokines that recruit and activate other innate and adaptive immune cells from the circulation to the site of infection. Major histocompatibility complex class I (MHC I), MHC II and co-stimulatory molecules, including CD80, CD86 and CD40, which are upregulated by Mtb infection, directly modulate the function of DCs in antigen presentation and T-cell activation [6, 7]. These biological functions of DCs trigger a range of cellular events that are capable of killing Mtb. However, Mtb has evolved numerous evasion mechanisms to hijack innate immune response for immune escape, leading to the chronic infection [8]. Taken together, the intracellular survival of Mtb is regarded as a compromise outcome of the host immune response and the resistance of Mtb. Hence, strengthening the immune responses of DCs in combating Mtb through HDT could be one of the potential approaches for effective bacterial killing and clearance of infection/disease.
Interferons (IFNs) therapy leads to beneficial or detrimental outcomes against TB, which is highly context dependent on different settings of host-bacteria encounters [9, 10]. This discrepancy might be due to hundreds of thousands of IFN-stimulated genes (ISGs) activated by IFNs with various functions. Virus-inhibitory protein, endoplasmic reticulum-associated, interferon-inducible (Viperin) encoded by Rsad2 is one of the important ISGs that participates in both innate and adaptive immune system in macrophages, DCs and T cells. It can interact with a large number of viral and host proteins to elicit host immune responses against a wide spectrum of viruses [11,12,13]. Viperin can be stimulated by a variety of stimulations such as IFNs, dsRNA, LPS or viruses [11]. However, the effects and mechanisms of Viperin on regulating DCs maturation and function during Mtb infection remain unknown.
In our study, we found that Viperin was up-regulated by Mtb infection. Viperin deficiency promoted phagocytosis and enhanced clearance of Mtb in DCs. Furthermore, Viperin deficiency significantly increased NO production, cytokine production including IL-12, TNF-α, IL-1β and IL-6, as well as chemokine production including CXCL1, CXCL2 and CXCL10. In addition, Viperin deficiency increased expression of major histocompatibility complex class I (MHC I), MHC II and co-stimulatory molecules, and enhanced DC functions in promoting CD4+ and CD8+ T-cell activation. Thus, we propose that Viperin suppresses DC functions and impedes the robust CD4+ and CD8+ T cell responses, which attenuate host immune surveillance, resulting in immune escape of Mtb. Thus, Viperin deficiency could boost the defense function of DCs, and we propose it constitutes a potential target for future HDT in TB therapy.
Methods
Ethics statement
This study was approved by the Ethics Committee of Southern Medical University. The Animal ethical certification and animal handling procedures were approved by the Animal Experimental Center in Southern Medical University. All experimental protocols were reviewed and approved by the Medical Ethics Board and the Biosafety Management Committee of Southern Medical University. Highly pathogenic microorganism laboratory management commitment letter was approved by Southern Medical University.
Mice
C57BL/6J mice were purchased from the Lab Animal Center of Southern Medical University (Guangzhou, China). Viperin deficient (Rsad2−/−) mice on a C57BL/6J background were built by Nanjing Biomedical Research Institute (Nanjing, China). OT-I mice were obtained from the Pathology Laboratory of Southern Medical University. OT-II mice were obtained from Fujian Medical University. All mice were maintained in the Lab Animal Center of Southern Medicine University under specific pathogen-free conditions.
Mtb culture and infection
Mtb standard strain H37Rv (American Type Culture Collection) was grown in 7H9 (Becton Dickinson, New Jersey, USA) broth containing 0.2% glycerol (GHTECH, Guangzhou, China) and 10% OADC at 37 °C in 5% CO2, OADC consists of 0.06% volume oleic acid (SIGMA, St. Louis, MO, USA), 5% albumin (SIGMA, St. Louis, MO, USA), 100 mM glucose (GHTECH, Guangzhou, China), 0.003% catalase (SIGMA, St. Louis, MO, USA), 145 mM NaCl (GHTECH, Guangzhou, China). Ground the agglomerated H37Rv into a bacterial suspension with cell culture medium or PBS and measured the absorbance at 600 nm. After the concentration was calculated, the cells were infected according to the multiplicity of infection (MOI) required by the experiment.
Cell culture
For generation of bone marrow-derived dendritic cells (BMDCs) from Rsad2+/+ and Rsad2−/− mice, bone marrow cells from femurs and tibiae was flushed with RPMI-1640 medium (Corning, NY, USA), cultured in RPMI-1640 containing 10% FBS (Corning, NY, USA) and mGM-CSF (20 ng/ml; Pepro Tech, USA) at 37 °C in 5% CO2 after lysing red blood cells. Fresh medium (10 ml) containing the same ingredient was provided to the culture on day 3. At day 6, half of the volume (10 ml) was removed and centrifuged the cells at 1600 rpm for 5 min. Cells were resuspended with the same volume and ingredients of fresh medium and cultured in the Petri dishes. BMDCs were used on day 8, cell culture supernatants were removed and centrifuged at 1400 rpm for 5 min. Cells were resuspended in fresh medium containing 2 ng/ml of mGM-CSF and seeded in cell culture plates for further experiments.
Treatment of inhibitors in BMDCs
BMDCs were pretreated with NF-kappaB (NF-κB) p65 inhibitor JSH-23 (20 µM; Selleckchem, Houston, USA) or iNOS inhibitor L-NAME HCl (1 mM; Selleckchem, Houston, USA) for 1 h before Mtb infection.
RNA extraction and quantitative real time PCR (qRT-PCR)
Total cellular RNA was extracted by Trizol method, and RNA concentration was measured by NanoDrop 2000 (Thermo Fisher Scientific, Carlsbad, CA, USA). RNA was reverse transcribed into cDNA using HonorTM II 1st Strand cDNA Synthesis SuperMix (Novogene, Beijing, China) after removal of genomic DNA (gDNA). CDNA was added to a mixture of Unique Aptamer qPCR SYBR Green Master Mix (Novogene, Beijing, China) and primers (Sangon Biotech, Shanghai, China) to detect the expression of related genes on a LightCycler 480 thermocycler (Roche, Basel, Switzerland). A three-step reaction method was used to perform qPCR, after a 2-min preincubation at 95 °C, target genes were amplified and quantified (95 °C for 15 s, 65 °C for 15 s, 68 °C for 20 s) for 45 cycles, followed by a 30 s cooling at 37 °C. All PCR products were normalized using GAPDH as an internal control, the expression of individual gene was calculated using the 2−△△CT method and expressed as fold change. The complete mouse primers are GAPDH (F: CATCACTGCCACCCAGAAGACTG, R: ATGCCAGTGAGCTTCCCGTTCAG); Rsad2 (F: GGAAGGTTTTCCAGTGCCTCCT, R: ACAGGACACCTCTTTGTGACGC); IL-12p40 (F: TTGAACTGGCGTTGGAAGCACG, R: CCACCTGTGAGTTCTTCAAAGGC); TNF (F: GGTGCCTATGTCTCAGCCTCTT, R: GCCATAGAACTGATGAGAGGGAG); IL-1β (F: TGGACCTTCCAGGATGAGGACA, R: GTTCATCTCGGAGCCTGTAGTG); IL-6 (F: TACCACTTCACAAGTCGGAGGC, R: CTGCAAGTGCATCATCGTTGTTC); iNOS (F: GAGACAGGGAAGTCTGAAGCAC, R: CCAGCAGTAGTTGCTCCTCTTC); CXCL1 (F: TCCAGAGCTTGAAGGTGTTGCC, R: AACCAAGGGAGCTTCAGGGTCA); CXCL2 (F: CATCCAGAGCTTGAGTGTGACG, R: GGCTTCAGGGTCAAGGCAAACT); CXCL10 (F: ATCATCCCTGCGAGCCTATCCT, R: GACCTTTTTTGGCTAAACGCTTTC); SLC2α1 (F: GCTTCTCCAACTGGACCTCAAAC, R: ACGAGGAGCACCGTGAAGATGA); PFKFB3 (F: TCATCGAGTCGGTCTGTGACGA, R: CATGGCTTCTGCTGAGTTGCAG); HK2 (F: CCCTGTGAAGATGTTGCCCACT, R: CCTTCGCTTGCCATTACGCACG); PDK1 (F: CCACTGAGGAAGATCGACAGAC, R: AGAGGCGTGATATGGGCAATCC); HIF-1α (F: CCTGCACTGAATCAAGAGGTTGC, R: CCATCAGAAGGACTTGCTGGCT); TKT (F: GCTAACATCCGAATGCCTACGC, R: T TGGTGTCTCCATCCAGGGCAA).
Protein sample preparation and western blot analysis
Cells were harvested and washed twice with ice-cold PBS, and then collected in ice-cold lysis buffer containing 455 mM Tris HCl (pH 6.8) (Sangon Biotech, Shanghai, China), 41.6 mM SDS (Zhuosheng Biotech, Shanghai, China), 26.9 μM bromophenol blue (Solarbio), 30% (v/v) glycerol (SIGMA, St. Louis, MO, USA), and 10 μM DL-Dithiothreitol (DTT) (SIGMA, St. Louis, MO, USA). They were heated at 95 °C for 10 min to fully denature the protein. Equal amounts of cell lysates were loaded into 8–15% polyacrylamide gels. After electrophoresis, proteins were electric transferred onto a polyvinylidene difluoride (PVDF) membrane (Merck KGaA, Germany). Membranes were blocked in 5% (w/v) BSA (SIGMA, St. Louis, MO, USA) in PBST for 1 h at room temperature and incubated overnight with primary antibodies at 4 °C. The membranes were washed three times with PBST for 10 min each time, and incubated with HRP-conjugated goat anti-rabbit or goat anti-mouse secondary antibodies (Thermo Fisher Scientific, Carlsbad, CA, USA) for 1 h at room temperature. After washing the membranes three times with PBST for 10 min each time, the immunoblots were visualized with Immobilon Western Chemiluminescence HRP substrate (ECL; Thermo Fisher Scientific, USA) on FluorChem Systems (ProteinSimple, USA) according to the manufacturer’s protocol. The integrated density of all protein bands were analyzed by Image J software (National Institutes of Health) and normalized to β-Actin or GAPDH. All the antibodies used in this project are listed in Supplemental Table 1.
Phagocytosis assay
BMDCs were seeded in 12-well cell culture plates (CELLTER, China) at the 5 × 105 cells per well for 24 h. Cells were harvested and incubated with OVA-FITC (Bohu Biotec, Shanghai, China) and fluorescently conjugated mAb CD11c+ at 37 ℃ in 5% CO2 for 30 min, or collected after infected with Texas Red (SIGMA, St. Louis, MO, USA) tagged H37Rv for 2 h at MOI = 5 and incubated with mAb CD11c+ at 4 °C for 30 min. The whole process needs to be protected from light. Then we analyzed the percentage of positive cells and relative median fluorescence intensity (MFI) in Texas-Red and FITC by flow cytometry and cells were gated on CD11c+.
Flow cytometry analysis
Cells were centrifuged at 1600 rpm for 5 min and washed once with 1% BSA/PBS. Then cells were incubated with mixtures of fluorescently conjugated mAbs for 30 min at 4 °C and washes twice with 1% BSA/PBS. Cell phenotypes were analyzed by flow cytometry on BD LSR II Fortessa X-20 (BD Biosciences, USA). Data were acquired as the fraction of labeled cells or MFI within a live-cell gate using FlowJo software. All gates were set on the basis of isotype-matched control antibodies. MAbs of mice were as follows: V450-anti-MHC I, PE-Cy7-anti-MHC II, V450-anti-CD40 (eBioscience, Carlsbad, CA, USA), FITC-anti-CD80, APC-anti-CD86, FITC-anti-CD3, PerCP-Cy5.5-anti-CD4+, APC-anti-CD8+, PE-Cy7-CD69 (TONBO Bioscience, San Diego, CA, USA).
Colony-forming units (CFU) assay
BMDCs were seeded in 12-well plates at 5 × 105 cells per well for 24 h and cells were infected with H37Rv at MOI of 5 at 37 °C in 5% CO2 for 1 h. To remove the extracellular H37Rv, the cells were thoroughly washed three times with PBS. The cells used to detect the amount of phagocytosis were lysed and diluted with 0.01% TritonX-100 (Solarbio, Beijing, China). 50 μl of the dilution was evenly spread on the 7H10 agar plates (Becton Dickinson, New Jersey, USA) supplemented with 10% OADC. Other cells were incubated in RPMI-1640 containing 10% FBS and mGM-CSF (2 ng/ml) at 37 °C in 5% CO2 for 48 and 72 h later. Then, they were lysed and diluted and plated on 7H10 agar plates in the same way. All plates were placed upside down at 37 °C in 5% CO2 and counted after colony growth.
Enzyme-linked immunosorbent assay (ELISA)
Cell culture supernatant was collected and filtered through a 0.22 μm filter to remove cell debris and Mtb. The secretion of cytokines (IL-12p70, TNF-α, IL-1β and IL-6) and chemokines (CXCL1, CXCL2, CXCL10, CCL3 and CCL4) in the supernatant was analyzed by respective ELISA kit (MultiSciences, Hangzhou, China). All procedures were performed according to the manufacturer’s instructions. Absorbance at 450 nm and 630 nm was detected by a Microplate Reader (TECAN SPARK, Austria).
Assay of cholesterol
Cholesterol content of BMDCs was detected with the Amplite™ Cholesterol Quantitation Kit (AAT Bioquest, Sunnyvale, CA, USA). BMDCs were seeded at 5 × 105 cells per well of 12 wells plate and infected with H37Rv at MOI = 2 for 24 h. Cells were lysed with 1 ml of 0.1% TritonX-200 per well after washing three times with PBS. Reagents were prepared according to the manufacturer’s protocol. 50 μl lysates were layouted and standard in a solid black 96-well microplate. Then, 50 μl cholesterol assay working solution was added into each well and cells were incubated at 37 °C for 30 min, protected from light. Fluorescence intensity was monitored at Ex/Em = 540/590 nm using a Microplate Reader (TECAN SPARK, Austria).
Nitric oxide (NO) measurement
Griess-Reagent System (Promega, Madison, USA) was used to detect NO production of BMDCs. 50 μlstandard diluted as instructed and 50 μl cell supernatant were added in a round-bottom 96-well plate. Then, 50 μl sulfanilamide solution was added and incubated them for 5–10 min at room temperature, protected from light. 50 μl NED solution was added to all wells and the reaction was incubated at room temperature for another 5–10 min, protected from light. Absorbance was measured within 30 min with a Microplate Reader (TECAN SPARK, Austria) between 520 and 550 nm. NO concentration was calculated according to the standard curve.
Antigen presentation assays
BMDCs were seeded at 1 × 106 cells per well in 6 wells plate (CELLTER, China). CD4+ T cells from OT-II mice or CD8+ T cells from OT-I mice were purified by CD4+ or CD8+ microbeads (Miltenyi Biotec, Germany). To detect cell proliferation, cells were labeled with CFSE (2 μM; Selleckchem, Houston, USA) at 37 °C for 20 min. To detect cell activation, cells were resuspended with RPMI-1640 containing 10% FBS and IL-2 (20 ng/ml) and seeded at 5 × 104 cells per well in round-bottomed 96-well plates. The next day, BMDCs were incubated with OVA (1 mg/ml; Bohu Biotec, Shanghai, China) and OVA323–339 (1 μg/ml; Sangon Biotech, Shanghai, China) or OVA257–264 (1 μg/ml; Sangon Biotech, Shanghai, China) for 6 h, washed twice with RPMI-1640 containing 10% FBS and IL-2 (20 ng/ml; Pepro Tech, USA) and co-cultured with purified T cells at a ratio of DC: T cell = 1: 10 for 24 h, flow cytometry analysis of the expression of activation index CD69. For 72 h, proliferation was determined by detecting the fluorescence intensity of CFSE via flow cytometry.
Statistical analysis
Data are expressed as mean ± SD at least three independent experiments. Determination of statistical differences was performed with Graphpad Prism 6.0 Software using Student t-test. *p ≤ 0.05, **p ≤ 0.01 were considered as statistically significant.
Results
Mtb infection promotes viperin expression in DCs
BMDCs were infected with H37Rv at different time points and Viperin expression levels were determined. Viperin mRNA expression significantly increased at 6, 24 and 48 h and the peak expression was induced at 24 h after Mtb infection (Fig. 1A). Viperin protein expression was significantly induced at 6, 24 and 48 h, and the peak expression was at 24 h (Fig. 1B). These results indicate that Viperin expression increased by Mtb infection may play a key role in regulating immune response in DCs.
Viperin deficiency promotes phagocytic function of DCs and suppresses Mtb clearance
We applied Viperin-deficient (Rsad2−/−) mice to investigate the role of Viperin in regulating phagocytic function of DCs. Neither mRNA nor protein expression of Viperin was detected in Rsad2−/− BMDCs with Mtb infection for 24 h, indicating successful disruption of Rsad2 in BMDCs (Fig. 2A and B). Next, BMDCs phagocytic OVA-FITC and H37Rv with Texas Red were detected by flow cytometry. The results showed that Viperin deficiency significantly promoted amounts of OVA and H37Rv within DCs, indicating that Viperin inhibited the phagocytic function of DCs (Fig. 2C and D). Moreover, we found that Viperin deficiency led to significant decrease of Mtb infection at 48 and 72 h in DCs detected by CFU assay (Fig. 2E). These results indicate that Viperin inhibits phagocytic function of DCs and increases Mtb infection in DCs.
Viperin deficiency elicits robust cytokine, chemokine and NO production in DCs
A subset of proinflammatory cytokines and chemokines produced by DCs play vital roles in recruiting and activating different immune cells to the site of Mtb infection. We detected cytokine and chemokine mRNA abundance by qRT-PCR and validated the production by ELISA assay. We obtained that cytokines including IL-12p40/IL-12p70, TNF-α, IL-1β and IL-6 were significantly increased in Rsad2−/− BMDCs compared with those in Rsad2+/+ BMDCs (Fig. 3A and B). Chemokines including CXCL1, CXCL2 and CXCL10 production were significantly increased in Viperin deficient BMDCs (Fig. 3C and D). However, the production of cytokine TGF-β and chemokines of CCL3 and CCL4 were not influenced in Rsad2−/− BMDCs with Mtb infection (Supplementary Fig. 1A and B). Cholesterol accumulation, metabolic process and autophagy have been reported that contribute to manipulating immune responses against Mtb infection in DCs [14,15,16,17]. Here, however, cholesterol production, expression of important enzymes in the glycolytic pathway including SLC2α, PFKFB3, HK2, PDK1, HIF-1α, TKT or autophagy were not affected in Rsad2−/− BMDCs with Mtb infection (Supplementary Fig. 1C–E). Reactive oxygen/nitrogen species and NO production are critical host defense pathways in determining the fate of intracellular Mtb within phagocytes. We further investigated whether Viperin deficiency influences iNOS expression and NO production. We demonstrated that mRNA and protein abundance of iNOS were significantly increased upon Mtb infection in Rsad2−/− BMDCs (Fig. 3E and F). Consistently, NO production was observed with significant increase (Fig. 3G). These results suggest that Viperin deficiency elicits robust cytokine, chemokine and NO production of DCs.
Viperin deficiency enhances expression of MHC I, II and co-stimulatory molecules in Mtb infected-DCs
MHC I, MHC II and co-stimulatory molecules, including CD80, CD86 and CD40, which are upregulated by Mtb infection, directly modulate the function of DCs in their antigen presentation and T cell immune responses against Mtb. We detected MHC I, II and co-stimulatory molecules of CD80, CD86 and CD40 expression by flow cytometry, and the results showed that expression of all these molecule were significantly enhanced in Rsad2−/− BMDCs with Mtb infection for 24 h (Fig. 4A and B).
Viperin deficiency promotes DC-mediated cross-priming of CD4+ and CD8+ T-cell activation
To investigate how Viperin regulates T cell responses, we co-cultured DCs with naïve ovalbumin-specific TCR transgenic CD4+ T cells (OT-II) for 6 h in the presence of OVA or cognate peptide (OVA323–339). The results showed that Viperin deficiency significantly increased the proportion of CD4+ CD69+ T cells (Fig. 5A and B). Next, we used fluorescent tag CFSE to detect cell proliferation. Fluorescent tags can be evenly distributed to two daughter cells during cell proliferation and its fluorescence intensity is half of parental cells. CD4+ T cells were sorted and co-cultured with BMDCs under the stimulation of OVA or OVA323–339 for 72 h. CD4+ T cells were collected and detected for the fluorescence intensity of CFSE by flow cytometry. We observed that Viperin deficiency led to decrease the fluorescence intensity of CFSE, indicating higher proliferation ability of CD4+ T cells (Fig. 5C and D). Then, we co-cultured DCs with naïve ovalbumin-specific TCR transgenic CD8+ T cells (OT-I) for 6 h in the presence of OVA or cognate peptide (OVA257–264). We found that Viperin deficiency significantly increased the proportion of CD8+ CD69+ T cells (Fig. 5E and F). We conclude that Viperin inhibits the antigen presentation ability of BMDCs, which subsequently inhibits T cell activation and proliferation.
Viperin regulates DC function though activating NF-κB p65
It is reported that Viperin was associated with both IRAK1 and TRAF6 and activated downstream signaling. To further investigate the exact mechanisms of Viperin in regulating DC functions, we detected TAK1, IKKα/β, MAPKs and NF-κB activation by Western blot analysis. The results showed that phosphorylation of TAK1, IKKα/β, MAPKs SAPK/JNK, ERK1/2 and p38 were not affected by Viperin deficiency after Mtb infection for 15, 30 and 60 min (Supplementary Fig. 2A). NF-κB p65 phosphorylation was significantly increased in Rsad2−/− BMDCs compared with Rsad2+/+ BMDCs with Mtb infection (Fig. 6A). Next, we applied NF-κB p65 inhibitor JSH-23 in Rsad2−/− BMDCs, and found that Viperin deficiency induced iNOS expression and NO production were impaired by JSH-23 treatment (Fig. 6B and) C). NO inhibitor L-NAME HCl treatment inhibited Viperin deficiency induced phagocytosis of Mtb within DCs (Fig. 6D), but did not influence MHC II, CD80 and CD86 expression (Supplementary Fig. 2B). These results indicated that Viperin could suppress phagocytic function of DCs via NF-κB p65 activation and NO production. Moreover, JSH-23 treatment significantly repressed cytokine production of IL-12, TNF-α, IL-1β and IL-6 (Fig. 6E). Similarly, chemokine production including CXCL1, CXCL2 and CXCL10 expression was significantly reduced by JSH-23 treatment in Rsad2−/− BMDCs (Fig. 6F). Importantly, Viperin deficiency promoted MHC II, CD80, CD86 and CD40 expression was inhibited by JSH-23 treatment in Rsad2−/− BMDCs (Fig. 6G and H). Together, these results indicated that Viperin suppresses DC functions though NF-κB p65.
Discussion
DCs are critical for initiation of adaptive immune responses to eliminate invading Mtb. In this study, we demonstrated that Viperin deficiency DCs showed robust activation and enhanced CD4+ and CD8+ T cell responses. We have shown that Viperin deficient DCs produced higher levels of NO, cytokines and chemokines expression, elevated co-stimulatory molecules expression, and enhanced CD4+ and CD8+ T cell responses. These data suggest that Viperin deficiency could boost the immune responses of DCs during Mtb infection, and we propose it constituting a potential target for future HDT in TB therapy.
IFNs are originally identified on the basis of their antiviral effects. Recent studies have highlighted the production of IFNs by Mtb infection in macrophages and DCs [18]. Although production of IFNs in infected cells serves as a pivotal event in innate immune response, these cytokines modulate the proliferation, maturation, differentiation and activation of DCs, NK, Th1 and memory CD8+ T cells [19, 20]. IFNs can also link innate and adaptive immune response by activating DCs. However, little is known about how interferon stimulated genes (ISGs) function on different lymphocytes. Viperin is one of important ISGs that can regulate the infection by directly interacting with viral protein or modulating the immune response of macrophages, DCs and T cells. Viperin deficiency facilitates polarization of BMDMs into M1 and M2 macrophages and secretion of cytokines [21]. Viperin can be induced by IRF-3 and IRF-7 mediated production of IFNs and combat different virus infection in myeloid DCs [22, 23]. In one study, Viperin was induced by dsRNA and LPS, and facilitated TLR7- and TLR9-mediated production of type I IFNs in plasmacytoid DCs (pDCs) [11]. Similarly, another study reported that Viperin was upregulated in fully matured DCs, which promoted production of IFN-I and secretion of pro-inflammatory cytokines, leading to enhanced T cell proliferation for antitumor response [12]. Viperin promoted T cell receptor-induced GATA-3 activation and optimal Th2 cytokine production via NF-κB and AP-1 activation [13]. In this study, Mtb infection facilitated Viperin expression in monocyte derived DCs. These results suggest that Viperin might play a role in regulating immune response against Mtb infection. However, we demonstrated that during Mtb infection, Viperin suppressed the activation of DCs. This discrepancy of Viperin on functions of DCs might be due to various models and different stimulus sources. Although IFNs are essential for the activation of adaptive immune responses through modulating DC activity [24], several reports underline that high levels of IFNs played an opposite role in combating Mtb [25]. For example, IFNs could act as negative host factors under the control of IL-1 triggered PGE2 synthesis to determine the outcome of TB [26]. It suggests that IFNs, especially its down-stream ISGs could play different roles in immune responses against Mtb infection. Furthermore, Mtb has evolved tools and strategies to hijack the innate immune system, such as cytosolic escape, block of phagosome maturation, apoptosis, inflammasome activation/modulation as well as autophagy inhibition. As Viperin expression has been upregulated by Mtb infection (Fig. 1), identifying the role of Viperin in controlling DCs activation and function during Mtb infection is crucial for better understanding of immune response and will also have important clinical implications for TB treatment.
It is remarkable that NO production in macrophages is a major effector for anti-mycobacterial action in both experimental and human TB [5]. The phagocytosis of Mtb by DCs is important for host defense [4]. How Viperin regulates NO production and Mtb infection in DCs needs further investigation. Moreover, the high-output expression of NO plays a key role in host defenses against intracellular Mtb [5]. It is reported that DC-derived NO controls the balance of effector and regulatory DC differentiation [27]. Specific inhibitors of NO prevented human DC maturation, with decreased expression of MHC class II, costimulatory and CD83 molecules and reduced IL-12 production [28]. Recently, autophagy gains increased attention on its ability of manipulating immune responses against Mtb infection especially in DCs [14]. Although autophagy might contribute to antigen processing for MHC II presentation, we found that Viperin did not affect autophagy in Mtb-infected DCs. Cholesterol accumulation in the cell membrane of DCs enhanced MHC II dependent antigen presentation and CD4+ T cell activation [15, 16]. Metabolic processes and their molecular signaling pathways have the effect on DC development and differentiation [17]. It is reported that Viperin could inhibit virus infection via reduced cholesterol biosynthesis or improve glucose metabolism [29,30,31]. However, in this study, Viperin did not influence cholesterol production or gene expression of important enzymes in the glycolytic pathway including SLC2α, PFKFB3, HK2, PDK1, HIF-1α and TKT (Supplementary Fig. 1). Activation DCs by Mtb infection upregulates MHC I, II and co-stimulated factors of CD80, CD86 and CD40 expression, and increases production of proinflammatory cytokines such as IL-12, TNF-α, IL-1β and IL-6, which promotes antigen processing and presentation [6, 7]. Mtb-infected DCs produce chemokines orchestrating the recruitment of cells into the Mtb-infected lung and contribute to Mtb containment [32]. For example, mature DCs could produce CCL3 and CCL4 after Mtb infection, which further recruit immature DCs to the site of infection and replace the mobilized population. Mtb-infected mature DCs express several chemokines such as CCL3, CCL4 and CXCL10 to stimulate NK and T cell migration [18]. Mtb-induced CXCL1 and CXCL2 could play important roles in recruiting neutrophils to sites of infection and control the early infection [33]. Innate immunity initially predominates in anti-Mtb responses, the subsequent recruitment and activation of T lymphocytes is indispensable for combating Mtb. Most of the reports on the effects of Viperin were related to how it regulates the viral infection. However, some bacteria such as Shigella flexneri and Listeria monocytogenes could induce Viperin expression and Viperin has been shown to inhibit these bacterial infections by promoting type I interferon response. Viperin deficiency promoted cellular cholesterol and Shigella flexneri entry into cells. This study first highlighted the role of Viperin and the type I IFN response in the control of bacterial pathogens [34, 35]. In our study, we highlight that targeting Viperin could be a potential strategy to enhance DC-mediated immune response against Mtb infection.
Several researches have focused on the mechanisms of Viperin in regulating immune responses. Viperin could catalyze the conversion of cytidine triphosphate (CTP) to 3’-deoxy-3’,4’-didehydro-CTP (ddhCTP), and act as a chain terminator of the RNA-dependent RNA-polymerases from many viruses, via a SAM-dependent radical way [36]. It could also regulate other innate immune responses by binding MAVS and trigger macrophage polarization [21, 37]. In addition, Viperin has been demonstrated as a host factor to couple innate immune signaling to antiviral ribonucleotide synthesis by interacting with the kinase IRAK1 and the E3 ubiquitin ligase TRAF6 [38]. Another study reported that Viperin facilitated IRF-7 mediated IFN-I production and T cell proliferation to induce antitumor response, however, without affecting NF-κB p65 activation [12]. In this study, we found that Viperin did not influence TAK1, IKKα/β and MAPKs signaling activation, which are downstream factors of IRAK1 and TRAF6. However, Viperin deficiency activated NF-κB p65 signaling. Activation of NF-κB signaling in DC, triggered by either pathogen-associated molecular patterns or proinflammatory cytokines, induces most of the typical phenotypic and functional characteristics of mature DCs, inducing the expression of MHC II and co-stimulatory molecules [39,40,41]. In this study, we demonstrated that Viperin could inhibit phagocytosis of Mtb via NO production induced by NF-κB p65 phosphorylation. Furthermore, Viperin suppressed cytokine including IL-12, TNF-α, IL-1β, IL-6 and chemokine including CXCL1, CXCL2, CXCL10 production and co-stimulated factor expression of DCs during Mtb infection via inhibiting NF-κB p65 activation (Fig. 6). These results suggest that NF-κB p65 activation plays a key role in Viperin inhibiting DC activation and function during Mtb infection. However, the exact mechanistic details of Viperin interaction with NF-κB signaling require further investigation.
Conclusions
Given the role of DCs in anti-Mtb immunity, we sought to characterize the effects and mechanisms of Viperin on activating DCs during Mtb infection. In this study, we conclude that Viperin deficiency inhibits phagocytosis of Mtb, promotes clearance of Mtb in DCs, upregulates NO, cytokine and chemokine production, increases expression of MHC I, II and co-stimulatory molecules, and enhances DC function in promoting CD4+ and CD8+ T-cell activation (Fig. 7). We propose Viperin as a candidate target for adjunct HDT in TB, though, opposite effects of Viperin on promoting immune responses were observed in different experimental models. A better understanding and further investigation of Viperin may develop new strategies against Mtb infection and improve current treatment for TB patients.
Data availability
All data generated or analyzed during this study are included in this article [and/or] its supplementary material files. Further enquiries can be directed to the corresponding author.
References
Boom WH, Schaible UE, Achkar JM. The knowns and unknowns of latent Mycobacterium tuberculosis infection. J Clin Invest. 2021;131:3.
Kolloli A, Subbian S. Host-directed therapeutic strategies for tuberculosis. Front Med (Lausanne). 2017;4:171.
Stuve P, Minarrieta L, Erdmann H, Arnold-Schrauf C, Swallow M, Guderian M, et al. De novo fatty acid synthesis during mycobacterial infection is a prerequisite for the function of highly proliferative T cells, but not for dendritic cells or macrophages. Front Immunol. 2018;9:495.
Tzelepis F, Verway M, Daoud J, Gillard J, Hassani-Ardakani K, Dunn J, et al. Annexin1 regulates DC efferocytosis and cross-presentation during Mycobacterium tuberculosis infection. J Clin Invest. 2015;125(2):752–68.
Lee JS, Yang CS, Shin DM, Yuk JM, Son JW, Jo EK. Nitric oxide synthesis is modulated by 1,25-dihydroxyvitamin D3 and interferon-gamma in human macrophages after mycobacterial infection. Immune Netw. 2009;9(5):192–202.
Mihret A. The role of dendritic cells in Mycobacterium tuberculosis infection. Virulence. 2012;3(7):654–9.
Domingo-Gonzalez R, Prince O, Cooper A, Khader SA. Cytokines and chemokines in Mycobacterium tuberculosis infection. Microbiol Spectr. 2016;4:5.
Kilinc G, Saris A, Ottenhoff THM, Haks MC. Host-directed therapy to combat mycobacterial infections. Immunol Rev. 2021;301(1):62–83.
Zhou X, Yang J, Zhang Z, Zhang L, Lie L, Zhu B, et al. Interferon regulatory factor 1 eliminates mycobacteria by suppressing p70 S6 kinase via mechanistic target of rapamycin signaling. J Infect. 2019;79(3):262–76.
Zhou X, Zhang L, Lie L, Zhang Z, Zhu B, Yang J, et al. MxA suppresses TAK1-IKKα/β-NF-κB mediated inflammatory cytokine production to facilitate Mycobacterium tuberculosis infection. J Infect. 2020;81(2):231–41.
Saitoh T, Satoh T, Yamamoto N, Uematsu S, Takeuchi O, Kawai T, et al. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity. 2011;34(3):352–63.
Jang JS, Lee JH, Jung NC, Choi SY, Park SY, Yoo JY, et al. Rsad2 is necessary for mouse dendritic cell maturation via the IRF7-mediated signaling pathway. Cell Death Dis. 2018;9(8):823.
Qiu LQ, Cresswell P, Chin KC. Viperin is required for optimal Th2 responses and T-cell receptor-mediated activation of NF-kappaB and AP-1. Blood. 2009;113(15):3520–9.
Xia H, Green DR, Zou W. Autophagy in tumour immunity and therapy. Nat Rev Cancer. 2021;21(5):281–97.
Bonacina F, Coe D, Wang G, Longhi MP, Baragetti A, Moregola A, et al. Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation. Nat Commun. 2018;9(1):3083.
Westerterp M, Gautier EL, Ganda A, Molusky MM, Wang W, Fotakis P, et al. Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity. Cell Metab. 2017;25(6):1294–304 (e6).
He Z, Zhu X, Shi Z, Wu T, Wu L. Metabolic regulation of dendritic cell differentiation. Front Immunol. 2019;10:410.
Lande R, Giacomini E, Grassi T, Remoli ME, Iona E, Miettinen M, et al. IFN-alpha beta released by Mycobacterium tuberculosis-infected human dendritic cells induces the expression of CXCL10: selective recruitment of NK and activated T cells. J Immunol. 2003;170(3):1174–82.
Biron CA. Interferons alpha and beta as immune regulators–a new look. Immunity. 2001;14(6):661–4.
Santini SM, Lapenta C, Logozzi M, Parlato S, Spada M, Di Pucchio T, et al. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med. 2000;191(10):1777–88.
Eom J, Yoo J, Kim JJ, Lee JB, Choi W, Park CG, et al. Viperin deficiency promotes polarization of macrophages and secretion of M1 and M2 cytokines. Immune Netw. 2018;18(4): e32.
Lazear HM, Lancaster A, Wilkins C, Suthar MS, Huang A, Vick SC, et al. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLoS Pathog. 2013;9(1): e1003118.
Teng TS, Foo SS, Simamarta D, Lum FM, Teo TH, Lulla A, et al. Viperin restricts chikungunya virus replication and pathology. J Clin Invest. 2012;122(12):4447–60.
Casanova MF, Walker LC, Whitehouse PJ, Price DL. Abnormalities of the nucleus basalis in Down’s syndrome. Ann Neurol. 1985;18(3):310–3.
McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87–103.
Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, Gonzales J, et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature. 2014;511(7507):99–103.
Si C, Zhang R, Wu T, Lu G, Hu Y, Zhang H, et al. Dendritic cell-derived nitric oxide inhibits the differentiation of effector dendritic cells. Oncotarget. 2016;7(46):74834–45.
Adler HS, Simon A, Graulich E, Habermeier A, Bacher N, Friebe A, et al. Neuronal nitric oxide synthase modulates maturation of human dendritic cells. J Immunol. 2010;184(11):6025–34.
Grunkemeyer TJ, Ghosh S, Patel AM, Sajja K, Windak J, Basrur V, et al. The antiviral enzyme viperin inhibits cholesterol biosynthesis. J Biol Chem. 2021;297(1): 100824.
Tang HB, Lu ZL, Wei XK, Zhong TZ, Zhong YZ, Ouyang LX, et al. Viperin inhibits rabies virus replication via reduced cholesterol and sphingomyelin and is regulated upstream by TLR4. Sci Rep. 2016;6:30529.
Qi Z, Xia J, Xue X, Liu J, Liu W, Ding S. Targeting viperin improves diet-induced glucose intolerance but not adipose tissue inflammation. Oncotarget. 2017;8(60):101418–36.
Monin L, Khader SA. Chemokines in tuberculosis: the good, the bad and the ugly. Semin Immunol. 2014;26(6):552–8.
Boro M, Singh V, Balaji KN. Mycobacterium tuberculosis-triggered Hippo pathway orchestrates CXCL1/2 expression to modulate host immune responses. Sci Rep. 2016;6:37695.
Helbig KJ, Teh MY, Crosse KM, Monson EA, Smith M, Tran EN, et al. The interferon stimulated gene viperin, restricts Shigella. flexneri in vitro. Sci Rep. 2019;9(1):15598.
Rivera-Serrano EE, Gizzi AS, Arnold JJ, Grove TL, Almo SC, Cameron CE. Viperin reveals its true function. Annu Rev Virol. 2020;7(1):421–46.
Gizzi AS, Grove TL, Arnold JJ, Jose J, Jangra RK, Garforth SJ, et al. A naturally occurring antiviral ribonucleotide encoded by the human genome. Nature. 2018;558(7711):610–4.
Hee JS, Cresswell P. Viperin interaction with mitochondrial antiviral signaling protein (MAVS) limits viperin-mediated inhibition of the interferon response in macrophages. PLoS One. 2017;12(2): e0172236.
Dumbrepatil AB, Ghosh S, Zegalia KA, Malec PA, Hoff JD, Kennedy RT, et al. Viperin interacts with the kinase IRAK1 and the E3 ubiquitin ligase TRAF6, coupling innate immune signaling to antiviral ribonucleotide synthesis. J Biol Chem. 2019;294(17):6888–98.
Lyakh LA, Koski GK, Telford W, Gress RE, Cohen PA, Rice NR. Bacterial lipopolysaccharide, TNF-alpha, and calcium ionophore under serum-free conditions promote rapid dendritic cell-like differentiation in CD14+ monocytes through distinct pathways that activate NK-kappa B. J Immunol. 2000;165(7):3647–55.
Rescigno M, Martino M, Sutherland CL, Gold MR, Ricciardi-Castagnoli P. Dendritic cell survival and maturation are regulated by different signaling pathways. J Exp Med. 1998;188(11):2175–80.
Zhu B, Zhu L, Xia L, Xiong Y, Yin Q, Rui K. Roles of ubiquitination and deubiquitination in regulating dendritic cell maturation and function. Front Immunol. 2020;11: 586613.
Acknowledgements
We thank Prof. Wei Yang for providing OT-I mice from the Pathology Laboratory of Southern Medical University. We thank Prof. Ping Lie for providing OT-II mice from Fujian Medical University.
Funding
This work was supported by National Natural Science Foundation of China (82072242, 82272344, 82070010), Natural Science Foundation of Guangdong Province (2021A1515010933, 2019A1515010988), Science and Technology Project of Guangzhou (202201010837).
Author information
Authors and Affiliations
Contributions
XZ contributed to the study concept and design, study supervision, obtained funding, XZ and HX acquisition of data, analysis and interpretation of data, drafting of the manuscript, statistical analysis and critical revision of the manuscript; QL, QW, HL, YH, YL, LL, ZH, YH, YC and WZ contributed to acquisition of data. QW, SH and CZ contributed to the critical revision of the manuscript; LM contributed to study concept and design, obtained funding, study supervision, and critical revision of the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Statement of ethics
This study was approved by the Ethics Committee of Southern Medical University. The Animal ethical certification and animal handling procedures were approved by the Animal Experimental Center in Southern Medical University. All experimental protocols were reviewed and approved by the Medical Ethics Board and the Biosafety Management Committee of Southern Medical University. Highly pathogenic microorganism laboratory management commitment letter was approved by Southern Medical University.
Consent for publication
Not applicable.
Additional information
Responsible Editor: John Di Battista.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhou, X., Xu, H., Li, Q. et al. Viperin deficiency promotes dendritic cell activation and function via NF-kappaB activation during Mycobacterium tuberculosis infection. Inflamm. Res. 72, 27–41 (2023). https://doi.org/10.1007/s00011-022-01638-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-022-01638-3